IL143687A0 - The process for manufacturing formulation of topical beta blockers with improved efficacy - Google Patents

The process for manufacturing formulation of topical beta blockers with improved efficacy

Info

Publication number
IL143687A0
IL143687A0 IL14368799A IL14368799A IL143687A0 IL 143687 A0 IL143687 A0 IL 143687A0 IL 14368799 A IL14368799 A IL 14368799A IL 14368799 A IL14368799 A IL 14368799A IL 143687 A0 IL143687 A0 IL 143687A0
Authority
IL
Israel
Prior art keywords
improved efficacy
beta blockers
topical beta
manufacturing formulation
formulation
Prior art date
Application number
IL14368799A
Other languages
English (en)
Original Assignee
Khamar Bakulesh Mafatlal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Khamar Bakulesh Mafatlal filed Critical Khamar Bakulesh Mafatlal
Publication of IL143687A0 publication Critical patent/IL143687A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14368799A 1998-12-11 1999-03-04 The process for manufacturing formulation of topical beta blockers with improved efficacy IL143687A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LK1157898 1998-12-11
PCT/IB1999/000378 WO2000035439A1 (en) 1998-12-11 1999-03-04 The process for manufacturing formulation of topical beta blockers with improved efficacy

Publications (1)

Publication Number Publication Date
IL143687A0 true IL143687A0 (en) 2002-04-21

Family

ID=19720977

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14368799A IL143687A0 (en) 1998-12-11 1999-03-04 The process for manufacturing formulation of topical beta blockers with improved efficacy

Country Status (10)

Country Link
EP (1) EP1137407B1 (de)
AP (1) AP2001002206A0 (de)
AU (1) AU770365B2 (de)
BR (1) BR9916107A (de)
CA (1) CA2354765A1 (de)
DK (1) DK1137407T3 (de)
EA (1) EA004050B1 (de)
IL (1) IL143687A0 (de)
RU (1) RU2218156C2 (de)
WO (1) WO2000035439A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008055205A2 (en) * 2006-10-31 2008-05-08 Alcon Research, Ltd. Pai-1 binding modulators for the treatment of ocular disorders
CN104189906A (zh) 2007-01-29 2014-12-10 V生命科学技术有限公司 用于治疗糖尿病并发症的药用组合物
EP4126076A1 (de) 2020-03-31 2023-02-08 Sentiss Pharma Private Limited Sterilisationsverfahren von timololgelbildender lösung durch aseptische filtration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
JPH0773394B2 (ja) * 1988-03-09 1995-08-02 富士通株式会社 異種通信網の一元的通信網への統合方法
EP0582321A1 (de) * 1992-01-17 1994-02-09 Gramer, Eugen, Prof.Dr.med.Dr.jur. Kombinationspräparat auf der Basis von Dipivalylepinephrin (DPE) und Betablocker zur Augeninnendrucksenkung

Also Published As

Publication number Publication date
CA2354765A1 (en) 2000-06-22
EA200100655A1 (ru) 2002-04-25
EA004050B1 (ru) 2003-12-25
AP2001002206A0 (en) 2001-09-30
EP1137407B1 (de) 2004-02-18
BR9916107A (pt) 2002-04-30
EP1137407A1 (de) 2001-10-04
AU770365B2 (en) 2004-02-19
DK1137407T3 (da) 2004-05-10
WO2000035439A1 (en) 2000-06-22
AU2541199A (en) 2000-07-03
RU2218156C2 (ru) 2003-12-10

Similar Documents

Publication Publication Date Title
GB9805815D0 (en) Manufacturing process
SG92745A1 (en) Absorbent article and process for manufacturing the same
GB9828074D0 (en) Therapeutically useful compounds
HUP0100215A3 (en) Process for the preparation of substantially amorphous alpha-ol
HUP0104823A3 (en) Sugar wafers
EP0993027A4 (de) Herstellung von verbindungshalbleitern
IL138824A0 (en) Process for manufacturing topical ophthalmic preparations without systemic effects
DE69827365D1 (de) Formulierungsverfahren für Schokolade
AU6371399A (en) Compounds comprising polyene chain structure and processes for preparing the same
HK1042163A1 (zh) 半導體製作方法
GB2352692B (en) Zone inspection manufacturing line
SG75906A1 (en) Integrated manufacturing packaging process
IL143687A0 (en) The process for manufacturing formulation of topical beta blockers with improved efficacy
DE69709481D1 (de) Herstellungsverfahren für Schokolade
GB2296374B (en) Fabricating semiconductor devices
GB9921487D0 (en) Manufacturing methods
GB9919654D0 (en) Manufacturing method
GB2313934B (en) Manufacturing production line
GB9819994D0 (en) Topical preparation
AU1701500A (en) A process for the manufacturing of a load carrier
GB0014741D0 (en) Manufacturing assembly
GB9917782D0 (en) Manufacturing assembly
PL353274A1 (en) Process for manufacturing detergent powder
EP1065709A4 (de) Vorrichtung zum herstellen von halbleiter
GB9910350D0 (en) Manufacturing method